OVID
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Sept 2023)
What this means for you
Registered since 07 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86842818
- Registration number
- 5157380
- Mark type
- Stylized text
- Filed
- 08 Dec 2015
- Published for opposition
- 03 May 2016
- Registered
- 07 Mar 2017
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical product evaluation * for the treatment of rare neurological diseases and disorders * ; pharmaceutical products development * for the treatment of rare neurological diseases and disorders * ; pharmaceutical research and development * for the treatment of rare neurological diseases and disorders *
Owner
- Ovid Therapeutics, Inc., New York, NY, US
- Ovid Therapeutics, Inc., New York, NY, US
- Ovid Therapeutics, Inc., New York, NY, US
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 07 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2018 — TTAB RELEASE CASE TO TRADEMARKS
- 06 Dec 2018 — CANCELLATION TERMINATED NO. 999999
- 03 Dec 2018 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 29 Nov 2018 — CANCELLATION DENIED NO. 999999
- 07 Sept 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Sept 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jul 2017 — CANCELLATION INSTITUTED NO. 999999
- 07 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 02 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED